Achievements and Challenges in Normal Tissue Response Modelling for Proton Therapy
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Muren L Phys Imaging Radiat Oncol. 2024; 29:100559.
PMID: 38434208 PMC: 10906384. DOI: 10.1016/j.phro.2024.100559.
Handeland A, Indelicato D, Fjaera L, Ytre-Hauge K, Pettersen H, Muren L Phys Imaging Radiat Oncol. 2023; 27:100466.
PMID: 37457667 PMC: 10345333. DOI: 10.1016/j.phro.2023.100466.
References
1.
Engeseth G, Hysing L, Yepes P, Pettersen H, Mohan R, Fuller C
. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer. Acta Oncol. 2021; 61(2):215-222.
PMC: 9969227.
DOI: 10.1080/0284186X.2021.1979248.
View
2.
Langendijk J, Lambin P, De Ruysscher D, Widder J, Bos M, Verheij M
. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013; 107(3):267-73.
DOI: 10.1016/j.radonc.2013.05.007.
View
3.
Arscott W, Thompson R, Yin L, Burgdorf B, Kirk M, Ben-Josef E
. Stereotactic body proton therapy for liver tumors: Dosimetric advantages and their radiobiological and clinical implications. Phys Imaging Radiat Oncol. 2021; 8:17-22.
PMC: 7807648.
DOI: 10.1016/j.phro.2018.11.004.
View
4.
Engeseth G, Stieb S, Mohamed A, He R, Stokkevag C, Brydoy M
. Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers. Radiother Oncol. 2020; 151:119-125.
PMC: 7674217.
DOI: 10.1016/j.radonc.2020.07.008.
View
5.
Christianen M, Schilstra C, Beetz I, Muijs C, Chouvalova O, Burlage F
. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2011; 105(1):107-14.
DOI: 10.1016/j.radonc.2011.08.009.
View